US EditionArgent Biopharma and Auscann sign deal to 'enhance drug development'
Summary by Cannabiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Argent Biopharma and Auscann sign deal to 'enhance drug development'
Argent Biopharma and Auscann have joined forces in a deal designed to “accelerate cannabinoid-based pharmaceutical development”. […] The post Argent Biopharma and Auscann sign deal to ‘enhance drug development’ appeared first on Cannabiz.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
